An italian biopharmaceutical company
The company is focused on the discovery, development and commercialization of monoclonal antibodies
Scientific Advisory Board
Fabio Malavasi, M.D., Professor of Medical Genetics, University of Turin, Italy;
Giampaolo Tortora, M.D., Professor of Medical Oncology, University Federico II, Naples, Italy;
Silvia Trasciatti, Ph.D., Director, Research and Development Division, Abiogen Pharma, Pisa, Italy;
Axel Ullrich, Ph.D., Director, Department of Molecular Biology, Max-Planck Institute, Martinsried, Germany.
Last updated: 10/02/2010 15:03Tag Cloud
Cancer biological therapy
Istituto Superiore di Sanita
products based on monoclonal antibodies
European Venture contest
Martinsried
product pipeline
Targeted therapy
Therapeutic antibodies
Monoclonal antibodies
Cancer drug companies
Business development
Mouse monoclonal
biopharmaceutical company
SP-2 0.1 mg Affinity purified
Research & Development
research antibodies
Turin
pharmaceutical company
Antibody production
research
Scientific Advisory Board
development
Cancer biodiagnostics
European cancer drug company
Cancer targeted therapy
Subscribe to Rss Feed
ShareMediaPharma S.r.l. P.IVA.: IT 02282760699 | Rea di Chieti: 166532
The information provided on www.mediapharma.it is designed to complement, not replace, the relationship between a patient and his/her own physician.
